The recommendations of the committee at the Central Drugs Standard
Control Organisation have been sent to the Drugs Controller General of
India for approval.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/panel-recommends-serum-institutes-name-for-phase-2-3-human-clinical-trials-of-oxford-vaccine-candidate/articleshow/77287839.cms
No comments:
Post a Comment